Farmington, MI, United States of America

Robert J Pauley


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Robert J Pauley

Introduction

Robert J Pauley is a notable inventor based in Farmington, MI (US). He has made significant contributions to the field of biomedical research, particularly in the development of human mammary epithelial cell sublines. With a total of 2 patents, his work has implications for cancer research and therapeutic applications.

Latest Patents

Pauley's latest patents focus on the creation of two immortalized human mammary epithelial cell sublines. These sublines do not undergo terminal differentiation and senescence when exposed to high calcium concentrations. They exhibit positive reactivity with milk-fat globule membrane and cytokeratin anti-sera, and are non-tumorigenic in athymic mice. These sublines are particularly useful for evaluating the capacity of preselected agents to influence epithelial cell growth and protein production.

Career Highlights

Robert J Pauley is associated with the Michigan Cancer Foundation, where he continues to advance his research. His work has been instrumental in providing valuable tools for cancer research and understanding cellular behavior in various environments.

Collaborations

Pauley has collaborated with notable colleagues such as Terry J Paine and Herbert D Soule. These partnerships have enhanced the scope and impact of his research endeavors.

Conclusion

Robert J Pauley's contributions to the field of biomedical research through his innovative patents and collaborations highlight his commitment to advancing scientific knowledge. His work continues to influence the understanding of human mammary epithelial cells and their applications in cancer research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…